SCHEMBL10160955

SCHEMBL10160955

c1ccc(-c2ccc(-n3c4ccccc4c4cc(N(c5ccccc5)c5ccc(-c6ccc7c(-c8ccccc8)c8ccccc8c(-c8ccccc8)c7c6)cc5)ccc43)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSPO P30536 4/20 0.40
KDM4E B2RXH2 1/20 0.40
ATM Q13315 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
KMT2A Q03164 1/20 0.35
HDAC4 P56524 1/20 0.35
PTGER4 P35408 1/20 0.32
RAC2 P15153 1/20 0.32
RAC3 P60763 1/20 0.32
CDC42 P60953 1/20 0.32
RAC1 P63000 1/20 0.32
EDNRA P25101 2/20 0.31
EDNRB P24530 1/20 0.31
NPY5R Q15761 1/20 0.31
DNM1 Q05193 1/20 0.31
IL1R1 P14778 1/20 0.30
RXRA P19793 1/20 0.30
RXRB P28702 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19296449 1.00 TSPO (0.40) TSPOKDM4EATML3MBTL1KMT2A
SCHEMBL2613590 0.98 L3MBTL1 (0.43) TSPOKDM4EATML3MBTL1KMT2A
SCHEMBL29363022 0.98 L3MBTL1 (0.43) TSPOKDM4EATML3MBTL1KMT2A
SCHEMBL392521 0.98 L3MBTL1 (0.43) TSPOKDM4EATML3MBTL1KMT2A
SCHEMBL10161115 0.96 L3MBTL1 (0.44) TSPOKDM4EATML3MBTL1KMT2A
SCHEMBL2613131 0.95 L3MBTL1 (0.41) TSPOKDM4EATML3MBTL1KMT2A
SCHEMBL10161126 0.95 L3MBTL1 (0.38) TSPOKDM4EATML3MBTL1KMT2A
SCHEMBL8406163 0.95 L3MBTL1 (0.45) TSPOKDM4EATML3MBTL1KMT2A
SCHEMBL2613578 0.95 L3MBTL1 (0.38) TSPOKDM4EATML3MBTL1KMT2A
SCHEMBL392879 0.95 L3MBTL1 (0.44) TSPOKDM4EATML3MBTL1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8288012-B2 Anthracene derivatives and light-emitting devices using the anthracene derivatives SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-10-16 US disclosed
US-8288012-B2 Anthracene derivatives and light-emitting devices using the anthracene derivatives SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-10-16 US disclosed
US-20120211728-A1 Light-Emitting Element, Light-Emitting Device, and Electronic Appliance SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-08-23 US disclosed
US-20120211728-A1 Light-Emitting Element, Light-Emitting Device, and Electronic Appliance SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-08-23 US disclosed
EP-2031036-B1 Light-emitting element, light-emitting device, and electronic appliance SEMICONDUCTOR ENERGY LAB (JP) 2012-06-27 EP disclosed
US-8101289-B2 Light-emitting element, light-emitting device, and electronic appliance SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-01-24 US disclosed
US-8101289-B2 Light-emitting element, light-emitting device, and electronic appliance SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-01-24 US disclosed
US-20090058278-A1 Light-Emitting Element, Light-Emitting Device, and Electronic Appliance SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2009-03-05 US disclosed
US-20090058278-A1 Light-Emitting Element, Light-Emitting Device, and Electronic Appliance SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2009-03-05 US disclosed
EP-2031036-A1 Light-emitting element, light-emitting device, and electronic appliance SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2009-03-04 EP disclosed
US-20090004506-A1 Anthracene Derivatives and Light-Emitting Devices Using the Anthracene Derivatives SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2009-01-01 US disclosed
US-20090004506-A1 Anthracene Derivatives and Light-Emitting Devices Using the Anthracene Derivatives SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2009-01-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090004506-A1 Anthracene Derivatives and Light-Emitting Devices Using the Anthracene Derivatives CRY1, CYP1A1, GLB1 TSPO 2918/4885KDM4E 3561/4885ATM 1030/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.